Eugene

[email protected]

LATEST

Fresenius Initiates Voluntary Recall of Sodium Chloride Injection Products
By

By
Fresenius Kabi, a specialty and generic pharmaceuticals company, is voluntarily recalling 163 lots of sodium chloride injection (USP, 0.9%, 10 mL) and sodium chloride injection (USP, 0.9%, 20 mL) to…

CASI Pharmaceuticals To Build GMP Manufacturing Site in China
By

By
CASI Pharmaceuticals, a Rockville, Maryland-headquartered biopharmaceutical company, has entered into framework agreements to build a manufacturing site located in Jiangsu Province, China. The company has a wholly owned subsidiary and…

Seqirus To Invest $140 Million to Expand Flu Vaccine Manufacturing
By

By
Seqirus, a subsidiary of CSL Limited and developer and manufacturer of influenza vaccines, is planning a $140-million expansion of its manufacturing facility in Holly Springs, North Carolina, as part of…

Cambrex To Acquire CDMO Avista Pharma Solutions for $252 Million
By

By
Cambrex, a contract manufacturing organization of small-molecule active pharmaceutical ingredients (APIs) and drug products, has agreed to acquire Avista Pharma Solutions, a Durham, North Carolina-headquartered contract testing, development, and manufacturing…

Sun Pharma To Acquire Pola Pharma and Manufacturing Facilities
By

By

FDA Invites Public Comment on the Use of Software in Rx Drugs
By

By
In a move to advance digital health technologies, the US Food and Drug Administration (FDA) has issued a Federal Register notice, “Prescription Drug-Use-Related Software” to seek early input from the…

European Commission Approves Takeda’s $62-Billion Proposed Acquisition of Shire
By

By
Takeda Pharmaceutical Company has received clearance from the European Commission (EC) for its proposed $62-billion acquisition of Shire. Takeda and Shire received clearance from the US Federal Trade Commission for…

Catalent, MilliporeSigma, Metrics, and More Expand; Samsung BioLogics, Biogen Close Asset Transfer
By

By
A roundup of the latest news from suppliers, contract development and manufacturing organizations and contract manufacturing organizations, featuring Catalent Pharma Solutions, MilliporeSigma, Metrics Contract Services, Samsung Biologics, PMI BioPharma Solutions,…

Allergan Nixes Plans for Plant Expansion in Texas
By

By
Allergan has decided not to pursue a $200-million expansion, first announced in 2016, at its manufacturing plant in Waco, Texas. Allergan had announced in 2016 plans to expand the Waco…

Moderna Therapeutics Files for $500-Million IPO
By

By
Moderna Therapeutics, a Cambridge, Massachusetts-based biotechnology company focusing on messenger RNA (mRNA) therapeutics, has filed a registration statement for an initial public offering with the US Securities and Exchange Commission…